HOME >> MEDICINE >> NEWS
NHLBI and NIH statements on totally implanted permanent artificial heart

for this device, it can mean longer life and a better quality of life.

Dr. Zerhouni:

For over half a century, scientists and engineers have dreamed of a total artificial heart. The National Heart, Lung, and Blood Institute's long-term commitment to this technology has helped to make this dream a reality. It is a shining example of an NIH institute supporting the development of a medical device that has great public impact from basic research through preclinical testing and on to clinical readiness. The total artificial heart will extend and improve the quality of life for patients who have no other treatment option.

This accomplishment also demonstrates the kind of long term interdisciplinary scientific efforts needed to address increasingly complex health challenges that often seem initially insurmountable to many. This could not have happened without the patient and far sighted leadership of NHLBI and NIH over several decades.


'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
5-Sep-2006


Page: 1 2

Related medicine news :

1. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
2. NHLBI awards 12 Womens Health Initiative contracts
3. NHLBI offers complete guide to physical activity for a healthy heart
4. NHLBI media availability: Low-fat dietary pattern and weight change
5. NHLBI research highlights at American Heart Associations scientific sessions
6. MGH named by NHLBI as Specialized Center for Cell-Based Therapy for Heart, Lung and Blood Diseases
7. New NHLBI-sponsored study shows programs can teach children to eat healthier
8. Miniature implanted devices could treat epilepsy, glaucoma
9. Are one-third of costly implanted heart devices unnecessary? New study suggests yes
10. New implanted contacts designed to fix nearsightedness
11. Test identifies best candidates for implanted cardiac defibrillator, screens out those not helped

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... owners, developers and operators of commercial real estate proudly announced that its service-based ... Health initiative. Team members portfolio-wide will continue Olshan Properties’ annual philanthropic tradition ...
(Date:5/4/2016)... ... 04, 2016 , ... Nike Rugby Camp's success is due in large part ... of Elite Rugby Camps and current Nike Camp director, has offered an all abilities ... , “I’m excited for our eighth summer here in San Diego,” says Willis. "We ...
(Date:5/4/2016)... NC (PRWEB) , ... May 04, 2016 , ... A ... in the world. The Duke Clinical Research Institute (DCRI) and analytics leader SAS will ... cardiovascular patient data collected by the Duke University Health System. , The DCRI ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
(Date:5/4/2016)... ... May 04, 2016 , ... May kicked off with Melanoma ... United States. Dermatologist Dr. Ellen Turner is encouraging her patients, as well as residents ... on skin safety and health now and in the future. , The dermatology-specific awareness ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... -- According to market research "Global Magnetic ... Demand Forecast to 2022 - Industry Insights by Architecture ... High Field, Low to Mid Field, and Ultra High ... Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" P&S ... was valued at $5,351.7 million in 2015, and it ...
(Date:5/3/2016)... , May 3, 2016 ... heute bekannt, dass sie einen entscheidenden Meilenstein ... haben: Ein Aufruf zum Handeln, um Patientenresultate ... Veröffentlichung trägt zu Fortschritten im Verständnis der ... hervor, ein Bewusstsein für Hepatische Enzephalopathie in ...
(Date:5/2/2016)... LAWRENCEVILLE, N.J. , May 2, 2016 /PRNewswire/ ... drug development company, today announced data from the ... dose escalating clinical trial (the OVATION Study) combining ... of care for the treatment of newly-diagnosed patients ... chemotherapy followed by interval debulking surgery.  In the ...
Breaking Medicine Technology:
Cached News: